Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1NET 1Endocrine 1

Conditions

Neuroendocrine Tumors 1Neoplasms 1

Interventions

Specimen Handling 477pembrolizumab 453Magnetic Resonance Spectroscopy 420Carboplatin 332Cyclophosphamide 311Cisplatin 273Biopsy 271Radiotherapy 245Paclitaxel 233Gemcitabine 228Bevacizumab 212Nivolumab 188fludarabine 184venetoclax 179Drug Therapy 170Dexamethasone 158Oxaliplatin 155Blood Specimen Collection 155Injections 153Capecitabine 151Fluorouracil 143Docetaxel 142Radiosurgery 133Standard of Care 132Rituximab 128Pemetrexed 123durvalumab 115atezolizumab 107Leucovorin 107Radiation 106

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × 68Ga-FAPI × 1 year × Clear all
NCT07132645 2025-09-23

An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer

University of Michigan Rogel Cancer Center

Phase EARLY_PHASE1 Recruiting
30 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT05034146 2025-06-05

68Ga-FAPI PET/CT in Malignant Tumors

Zhongnan Hospital

Phase NA Recruiting
500 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡